Market Closed -
Bombay S.E.
06:00:48 2024-05-10 am EDT
|
5-day change
|
1st Jan Change
|
1,985
INR
|
-0.80%
|
|
-5.50%
|
-15.89%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
10,658
|
8,062
|
4,477
|
7,065
|
15,346
|
16,069
|
Enterprise Value (EV)
1 |
10,152
|
7,697
|
4,709
|
7,525
|
15,513
|
16,252
|
P/E ratio
|
42.9
x
|
42.3
x
|
18.2
x
|
133
x
|
50.1
x
|
19.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.77
x
|
1.15
x
|
0.6
x
|
1.13
x
|
1.46
x
|
1.14
x
|
EV / Revenue
|
1.69
x
|
1.1
x
|
0.64
x
|
1.2
x
|
1.48
x
|
1.16
x
|
EV / EBITDA
|
24.7
x
|
17.7
x
|
8.66
x
|
38.3
x
|
17.6
x
|
10.4
x
|
EV / FCF
|
-19.7
x
|
-325
x
|
-8.49
x
|
-139
x
|
35
x
|
-2,310
x
|
FCF Yield
|
-5.07%
|
-0.31%
|
-11.8%
|
-0.72%
|
2.85%
|
-0.04%
|
Price to Book
|
3.49
x
|
2.48
x
|
1.28
x
|
2
x
|
3.99
x
|
3.45
x
|
Nbr of stocks (in thousands)
|
12,110
|
12,110
|
12,110
|
12,110
|
12,110
|
12,110
|
Reference price
2 |
880.0
|
665.7
|
369.6
|
583.4
|
1,267
|
1,327
|
Announcement Date
|
5/28/18
|
8/23/19
|
9/5/20
|
9/4/21
|
8/29/22
|
8/31/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
6,016
|
7,015
|
7,415
|
6,272
|
10,477
|
14,037
|
EBITDA
1 |
411.1
|
436
|
543.7
|
196.7
|
881.8
|
1,560
|
EBIT
1 |
349.7
|
357.1
|
464.2
|
102.1
|
768.7
|
1,435
|
Operating Margin
|
5.81%
|
5.09%
|
6.26%
|
1.63%
|
7.34%
|
10.22%
|
Earnings before Tax (EBT)
1 |
385.9
|
292.2
|
333.4
|
118.5
|
413.4
|
1,096
|
Net income
1 |
246.4
|
190.6
|
246.2
|
53.22
|
306.3
|
814.1
|
Net margin
|
4.1%
|
2.72%
|
3.32%
|
0.85%
|
2.92%
|
5.8%
|
EPS
2 |
20.51
|
15.73
|
20.33
|
4.390
|
25.29
|
67.22
|
Free Cash Flow
1 |
-514.4
|
-23.69
|
-554.9
|
-54.01
|
442.9
|
-7.034
|
FCF margin
|
-8.55%
|
-0.34%
|
-7.48%
|
-0.86%
|
4.23%
|
-0.05%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
50.22%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
144.56%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/28/18
|
8/23/19
|
9/5/20
|
9/4/21
|
8/29/22
|
8/31/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
232
|
460
|
166
|
182
|
Net Cash position
1 |
506
|
365
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
0.4275
x
|
2.341
x
|
0.1887
x
|
0.1168
x
|
Free Cash Flow
1 |
-514
|
-23.7
|
-555
|
-54
|
443
|
-7.03
|
ROE (net income / shareholders' equity)
|
8.98%
|
6.05%
|
7.31%
|
1.51%
|
8.3%
|
19.1%
|
ROA (Net income/ Total Assets)
|
4.93%
|
4.31%
|
5.06%
|
1.01%
|
6.21%
|
9.49%
|
Assets
1 |
4,995
|
4,426
|
4,869
|
5,287
|
4,934
|
8,580
|
Book Value Per Share
2 |
252.0
|
268.0
|
288.0
|
292.0
|
318.0
|
385.0
|
Cash Flow per Share
2 |
1.090
|
43.80
|
1.890
|
3.090
|
7.090
|
1.980
|
Capex
1 |
110
|
821
|
655
|
151
|
189
|
245
|
Capex / Sales
|
1.83%
|
11.7%
|
8.84%
|
2.4%
|
1.8%
|
1.75%
|
Announcement Date
|
5/28/18
|
8/23/19
|
9/5/20
|
9/4/21
|
8/29/22
|
8/31/23
|
|
1st Jan change
|
Capi.
|
---|
| -15.89% | 288M | | +17.73% | 66.69B | | +1.61% | 49.2B | | +16.33% | 41.24B | | +18.68% | 25.89B | | +12.78% | 19.81B | | -21.87% | 15.86B | | -10.29% | 15.23B | | +2.32% | 15.35B | | -22.30% | 13.36B |
Other Specialty Chemicals
|